As of 2024-12-13, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (9.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -239.7%.
The range of the Relative Valuation is (4.58) - (14.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 17.5x | 11.4x |
| Forward P/E multiples | 5.4x - 18.8x | 12.1x |
| Fair Price | (4.58) - (14.85) | (9.99) |
| Upside | -164.1% - -307.7% | -239.7% |
| Date | P/E |
| 2024-09-17 | -8.43 |
| 2024-09-16 | -8.43 |
| 2024-09-13 | -8.43 |
| 2024-09-12 | -8.40 |
| 2024-09-11 | -8.40 |
| 2024-09-10 | -8.40 |